Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation
| Document Type: | Article |
|---|---|
| Language: | English |
| Author: | Matthias Schoenberger, Mike Althaus |
| Parent Title (English): | Expert Opinion on Therapeutic Patents |
| Volume: | 23 |
| Issue: | 10 |
| Number of pages: | 7 |
| First Page: | 1383 |
| Last Page: | 1389 |
| ISSN: | 1354-3776 |
| DOI: | https://doi.org/10.1517/13543776.2013.829454 |
| PMID: | https://pubmed.ncbi.nlm.nih.gov/23957246 |
| Publisher: | Taylor & Francis |
| Date of first publication: | 2013/08/19 |
| Funding: | M Schoenberger is supported by the German Study Foundation; M Althaus is supported by grants from the German Research Foundation (DFG, AL1453/1-1 and AL1453/1-2). The authors state no conflict of interest and have received no payment in preparation of this manuscript |
| Keyword: | Amiloride; Epithelial sodium channel; airway rehydration; cystic fibrosis; mucociliary clearance |
| Departments, institutes and facilities: | Institut für funktionale Gen-Analytik (IFGA) |
| Dewey Decimal Classification (DDC): | 5 Naturwissenschaften und Mathematik / 57 Biowissenschaften; Biologie / 570 Biowissenschaften; Biologie |
| Entry in this database: | 2023/03/22 |
